For acquirers, searchers & investors

Know what you're actually buying.

The technology is the part of a target you can't see from the data room and won't feel until after close. Ampeer gives you an independent technical read – the risk you'd inherit, and the upside you could build – on the timeline a deal actually runs.

The problem

Every SaaS company looks clean on the surface.

Underneath, most are held together in ways you only discover after the deal closes.

You run your own financial and commercial diligence. The technology is the part your team is least equipped to read – and the part most likely to turn into a post-close surprise: a renegotiated earnout, a key engineer who walks, a rebuild you didn't price in.

I've been the operator on the other side of that – reviewing technical diligence on acquisitions, then running the acquired companies afterward. I know what a data room hides, what a founder genuinely doesn't know, and what only shows up in year two.

And it runs both ways. The same read that flags the risk also finds the upside – where the technology is a lever you could pull as the owner, not just a liability to manage.

What gets examined

The same eight domains – read for what you'd inherit.

Dependency & license provenance

The full dependency tree, copyleft exposure, and packages with no license at all – the obligations you'd inherit.

Architecture & concentration risk

Single points of failure, vendor and integration lock-in, cloud-cost efficiency, and what a migration would actually cost.

Security posture & evidence

Not whether they claim to be secure – whether they can prove it, from access control to data governance.

Operational resilience

Uptime, monitoring, and whether a restore has ever actually been tested – not just asserted in the data room.

Key person & knowledge risk

Bus factor computed from commit history – who you'd need to retain, and what walks out the door without them.

IP ownership & provenance

Contractor assignment, open-source contributions, and AI-generated code – whether they actually own what you're buying.

Delivery predictability

Whether the roadmap in the deck is supported by the team's actual throughput.

Scalability & performance

Whether the system can take the growth your thesis depends on – proven under load, not asserted.

How findings are sorted

Find. Fix. Frame.

Every finding is sorted by what can be done about it – what to fix after close, what's fine, and what to price into the deal. That sorting is the difference between a list of scary words and a decision you can actually make.

Find

Unknown

Never inventoried – by them or anyone. The risk you can't see from a data room.

Fix

Known but undocumented

Real practices, just unproven. Cheap to close once you own it – but you should know first.

Frame

Known but unfixable fast

Too expensive to change on deal timeline. You price it in, or plan the rebuild – with eyes open.

The engagement

An independent technical read, on deal timeline.

Scoped to the target and the clock you're on – mostly async, with a walkthrough for you and your investment committee. Diligence-fast when you need it.

Book a call
  1. 01 Inherited-Risk Register Every finding sorted fix-now / price-in / fine, each with the question to press the seller on.
  2. 02 Architecture Snapshot One page: the stack, dependencies, and concentration risk, in language your investment committee can read.
  3. 03 First-90-Days Plan If you buy: what to fix, integrate, or rebuild – sequenced by impact and cost.
  4. 04 Upside Read Where the technology is a lever, not just a liability – the value you could create as the owner.

After the deal

The read is the start. Someone has to run it afterward.

The value case usually depends on what happens after close – integrating the acquired product, keeping the team, and folding it in without stalling the roadmap. I do that too, as an interim operator or on retainer through the integration window – the same person who read the target, now accountable for the outcome.

Operating & fractional

Share internally

A concise overview for the deal team.

The technical diligence overview is designed to circulate with the people deciding what a target is worth.

Download the overview

Is this for you?

Best fit – and who should skip it.

Built for searchers, independent sponsors, lower-middle-market PE, family offices, and operators buying a company to run.

A fit, if

  • You're acquiring or investing in a B2B software company
  • You run your own financial and commercial diligence, but not the technical layer
  • The target is founder-led and has never been through a real process
  • You want to know what you'll inherit and what you could build – not just a checkbox

Probably not, if

  • You already have a seasoned technical partner in-house
  • You're buying for the cash flows and will ride the tech as-is
  • You need a rubber stamp, not a real read

Who's behind it

An operator who has been on your side of the table.

Most advisors have read a diligence report. I've run them from the buy-side – and then run the companies afterward – so I know what catches at diligence and what only surfaces once you own it.

2012 – Founding

Co-founded Gather

Co-founded Gather, an event-management platform for restaurants and venues. Led product and engineering; scaled it to $10M ARR and roughly 110 people.

2017 – Capital

Strategic investment from Vista Equity Partners

Gather took a strategic investment from Vista Equity Partners, followed by Enlightened Hospitality Investments – capital and partnership to accelerate the platform.

2020 – Platform leadership

Joined Tripleseat as VP Engineering, then GM

Gather merged with Tripleseat. As VP Engineering and then General Manager, helped grow ARR from $20M to $60M+, took the platform to SOC 2 and PCI compliance at 99.99% uptime, and built payments into a profit center.

2023–25 – Integration

Ran three acquired business lines

Served as GM across EventUp, Attendease, and Merri – owning post-acquisition integration and P&L for each line. This work ran through General Atlantic's majority stake at a reported ~$500M valuation.

Have a target in the works? Let's talk before you're committed.

A short call is the fastest way to figure out the read you need and the timeline it fits. No drawn-out sales process.

Book a call

Prefer email? tom@ampeer.com